GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹2,194 Cr | ₹991 Cr | ₹4,348 Cr | ₹3,670 Cr | ₹4,687 Cr |
What is the latest Total Debt ratio of GLENMARK PHARMACEUTICALS ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹2,194 Cr |
| Mar2024 | ₹991 Cr |
| Mar2023 | ₹4,348 Cr |
| Mar2022 | ₹3,670 Cr |
| Mar2021 | ₹4,687 Cr |
How is Total Debt of GLENMARK PHARMACEUTICALS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,194 Cr | 121.50 | |
| Mar2024 | ₹991 Cr | -77.22 | |
| Mar2023 | ₹4,348 Cr | 18.46 | |
| Mar2022 | ₹3,670 Cr | -21.70 | |
| Mar2021 | ₹4,687 Cr | - | |
Compare Total Debt of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹64,539.1 Cr | 5% | 1% | 7.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 5% |
1% |
7.8% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses